H100
目录号 : GC30555H100是一种氯离子运输(Cl-transport)抑制剂,可以部分抑制氯离子载体NaK2Clcotransporter和Band3anionexchanger,但是对KClcotransporter无作用。
Cas No.:643727-55-3
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Cell experiment: | 35SO42- efflux is used as a convenient measure of the activity of the Band 3 anion exchanger (AE). Erythrocytes are suspended into MBS containing Na2SO4 rather than NaCl and incubated at 37°C for 30 min. The cell suspension is then centrifuged (3,000 g, 5 min) and the supernatant removed. The above procedure is repeated twice to ensure the intracellular replacement of Cl- with SO42-. To load the erythrocytes with radiolabel, the packed cells are re-suspended to approximately 50% haematocrit in a solution containing 1 part SO42- MBS and 9 parts of a medium containing (in mM) 300 sucrose and 10 MOPS (pH 7.4, 300 ± 5 mOsm) and placed in a microcentrifuge tube. 10 μCi of 35SO42- is then added and the suspension incubated at 37°C for 1 h. At the end of this period, the cells are then washed four times by centrifugation (10,000 g, 10 s) in ice-cold SO42- MBS. All inhibitors (H100) are dissolved in either DMSO or MBS and are added to the cell suspensions prior to the addition of the radioisotope[1]. |
References: [1]. Culliford S1, et al. Specificity of classical and putative Cl(-) transport inhibitors on membrane transport pathways in human erythrocytes. Cell Physiol Biochem. 2003;13(4):181-8. |
H100 is a Cl- transport inhibitor, with partial effects against both the NaK2Cl cotransporter and the Band 3 anion exchanger, but no effect against KCl cotransporter, in human erythrocytes.
H100 is a Cl- transport inhibitor, with partial effects against both the NaK2Cl cotransporter (NKCC) and the Band 3 anion exchanger (AE), but no effect against KCl cotransporter (KCC), in human erythrocytes. H100 (0.1 mM) shows 63% and 74% inhibition of NKCC and AE in human erythrocytes[1].
[1]. Culliford S1, et al. Specificity of classical and putative Cl(-) transport inhibitors on membrane transport pathways in human erythrocytes. Cell Physiol Biochem. 2003;13(4):181-8.
Cas No. | 643727-55-3 | SDF | |
Canonical SMILES | O=C(O)C1=CC(N2C=CC=C2)=C(OC3=CC=C(OC)C=C3)C(S(=O)(N)=O)=C1 | ||
分子式 | C18H16N2O6S | 分子量 | 388.39 |
溶解度 | Soluble in DMSO | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.5747 mL | 12.8737 mL | 25.7473 mL |
5 mM | 0.5149 mL | 2.5747 mL | 5.1495 mL |
10 mM | 0.2575 mL | 1.2874 mL | 2.5747 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Correction: "Topical treatment for acute phase Peyronie's disease utilizing a new gel, H100: a randomized, prospective, placebo-controlled pilot study"
Interventional stem cell therapy
The ability to deliver cells in appropriate doses to their targeted site of action is a well-known obstacle to optimising stem cell therapy. Systemic administration of cells results in pulmonary "trapping," which significantly decreases the number of available circulating cells to impact underlying disorders. Directed delivery of stem cells in interventional radiology may provide an additional option for bypassing the lungs, as well as introduce novel potential avenues for decreasing doses required to effect cellular therapy, efficiently obtain local paracrine effects, and/or to simplify targeting strategies.
Thiol-Anhydride Dynamic Reversible Networks
The reaction of thiols and anhydrides to form ring opened thioester/acids is shown to be highly reversible and it is accordingly employed in the fabrication of covalent adaptable networks (CANs) that possess tunable dynamic covalent chemistry. Maleic, succinic, and phthalic anhydride derivatives were used as bifunctional reactants in systems with varied stoichiometries, catalyst, and loadings. Dynamic characteristics such as temperature-dependent stress relaxation, direct reprocessing and recycling abilities of a range of thiol-anhydride elastomers, glasses, composites and photopolymers are discussed. Depending on the catalyst strength, 100 % of externally imposed stresses were relaxed in the order of minutes to 2 hours at mild temperatures (80-120 °C). Pristine properties of the original materials were recovered following up to five cycles of a hot-press reprocessing technique (1 h/100 °C).
Taking to "heart" the proposed legislation for permanent daylight saving time
In March 2022, the US Senate passed the Sunshine Protection Act that would abolish the biannual change in clocks each fall and spring and permanently adopt daylight saving time that aligns with the "spring forward" time change each March. A number of scientific and medical societies have endorsed the abolishment of the biannual clock change, but oppose the permanent adoption of daylight saving time. Instead, leading organizations such as the American Academy of Sleep Medicine (AASM) and the Society for Research on Biological Rhythms (SRBR) position statements highlight peer-reviewed evidence in favor of a permanent shift to standard time. The present perspectives will summarize some of the key AASM and SRBR recommendations, with a particular focus on the potential cardiovascular implications of a legislative change that would result in a permanent switch to either standard time or daylight saving time. Collectively, although there is building scientific consensus that abolishing the biannual time change has several sleep and circadian health benefits, the preponderance of evidence is opposite to the current legislation and instead suggests a permanent switch to standard time may offer the maximum health and safety benefits. This scientific evidence should be considered as the United States House of Representatives considers the Sunshine Protection Act.
Effects of nordihydroguaiaretic acid on in vitro fermentation profiles of rumen bacteria
Nordihydroguaiaretic acid (NDGA) is a secondary plant metabolite with antimicrobial properties, and therefore may have potential as a rumen modifier. Two in vitro experiments were conducted to determine the usefulness of NDGA as a rumen modifier. Exp. 1 evaluated the effect of adding 0, 5, 10, 50, and 100 mg/mL NDGA on growth of pure and mixed cultures of rumen bacteria. Growth of all cultures except Butyrivibrio fibrisolvens H17c was inhibited at 50 mg/mL NDGA (P < 0.05). Cultures from whole rumen fluid and B. fibrisolvens H17c were inhibited with 100 mg/mL NDGA (P < 0.05). Exp. 2 evaluated additions of NDGA on IVDMD (48 h) and VFA production. Three dietary substrates simulating different resources available for livestock production and 5 concentrations of NDGA were compared with monensin (47.5 μg/mL, MON, Elanco Animal Health, Indianapolis, IN). Substrates included (DM basis) 100% meadow hay (H100), 50% alfalfa with 50% ground corn (H50), and 90% ground corn with 10% alfalfa (H10). Treatments were 0 (Control; CON), 20, 40, 60, 80 μg/mL NDGA and MON. Treatment means were compared using 2 single degree of freedom contrasts (0 μg/mL NDGA vs. MON and NDGA vs. MON) and orthogonal polynomial contrasts within NDGA concentrations. Monensin fermented with H100 had the least (P < 0.01) IVDMD. A linear increase in IVDMD was observed for H50 (P < 0.01) but not H10 or 100 (P > 0.40). Acetate was quadratic for all substrates tested with NDGA (P < 0.01) and adding NDGA vs. MON resulted in 9% greater values (P < 0.01). Propionate increased by addition of MON compared with CON, which was opposite for acetate. Propionate showed the greatest increase with addition of MON and was dependent on diet vs. CON (H100 vs.H50 vs. H10; 22.5%, 44.4%, and 30.2%, respectively). When H100 was used, total VFA declined linearly by 61% with increasing NDGA (P < 0.01), whereas H50 and H10 were quadratic (P < 0.01) with the greatest total VFA resulting from 40 and 80 mg/mL NDGA for H50 and H10, respectively. Addition of NDGA tended to decrease total VFA (P =0.06) for H100 and H10 by 18.5% and 9.0%, respectively; however, H50 did not differ (P = 0.82) compared with MON. Butyrate increased linearly with increasing NDGA for H10 (P < 0.03) and quadratic for H50 and H100 (P < 0.01). The lowest overall acetate:propionate ratio was obtained with addition of MON to H10 (1.35) and the greatest ratio resulted from adding 60 μg/mL NDGA to H100 (3.63). Rumen fermentation was responsive to NDGA, and the response is dependent on diet.